Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis.

Cell death & disease·2021
Same author

Addressing challenges to rolling out COVID-19 vaccines in African countries.

The Lancet. Global health·2021
Same author

Zoonotic Tuberculosis - The Changing Landscape.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2021
Same author

Accelerating development of new shorter TB treatment regimens in anticipation of a resurgence of multi-drug resistant TB due to the COVID-19 pandemic.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2021
Same author

Lethal zoonotic coronavirus infections of humans - comparative phylogenetics, epidemiology, transmission, and clinical features of coronavirus disease 2019, The Middle East respiratory syndrome and severe acute respiratory syndrome.

Current opinion in pulmonary medicine·2021
Same author

Host-directed therapies for COVID-19.

Current opinion in pulmonary medicine·2021
Same journal

From Parasite to Pill: Harnessing Biology for Breakthroughs in Antimalarial Drug Discovery.

Cold Spring Harbor perspectives in medicine·2026
Same journal

Malaria Parasite Genomics: Decentralization, Diversification, and Development Goals.

Cold Spring Harbor perspectives in medicine·2026
Same journal

HIV-Associated Tuberculosis in Adults: Diagnosis and Clinical Management.

Cold Spring Harbor perspectives in medicine·2026
Same journal

Dermatophytes: Global Pandemic, Multidrug Resistance, Human-to-Human, and Sexual Transmission.

Cold Spring Harbor perspectives in medicine·2026
Same journal

The Global Epidemiology of Tuberculosis: Burden, Trends, and Determinants.

Cold Spring Harbor perspectives in medicine·2026
Same journal

Diagnostic Assays for TB Disease and Drug Resistance Detection-Advances and Latest WHO Recommendations.

Cold Spring Harbor perspectives in medicine·2026
See all related articles
  1. Home
  3. Tuberculosis Infection: Diagnosis And Management.
  1. Home
  3. Tuberculosis Infection: Diagnosis And Management.

Related Experiment Video

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Tuberculosis Infection: Diagnosis and Management.

Ibrahim Abubakar1, Jeremiah Chakaya2, David Hui3

  • 1Institute for Global Health, University College London, London WC1E 6BT, United Kingdom i.abubakar@ucl.ac.uk.

Cold Spring Harbor Perspectives in Medicine
|May 26, 2026

View abstract on PubMed

Summary
This summary is machine-generated.

Managing tuberculosis (TB) infection is key to global TB elimination. This review covers TB infection

Related Experiment Videos

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Area of Science:

  • Infectious Diseases
  • Public Health
  • Epidemiology

Background:

  • Tuberculosis (TB) infection is the primary reservoir for the global TB epidemic and a crucial target for elimination efforts.
  • Contemporary understanding views TB infection not as static but as a dynamic spectrum with varying progression risks.

Purpose of the Study:

  • To synthesize current evidence on the natural history, epidemiology, diagnosis, treatment, and management of TB infection.
  • To examine advances and implementation gaps in TB preventive treatment strategies.

Main Methods:

  • Comprehensive review of existing literature and World Health Organization (WHO)-recommended diagnostic tools.
  • Analysis of interferon-γ release assays and antigen-specific skin tests, noting their limitations in predicting progression.
  • Examination of short-course rifamycin-based preventive regimens and strategies for drug-resistant TB exposure.

    • Main Results:

    • Current diagnostic tests have limitations in predicting individual progression risk.
    • Significant implementation gaps persist in the TB infection prevention cascade.
    • Advances in preventive treatment offer new opportunities for TB control.

    Conclusions:

    • Effective management of TB infection is central to achieving global TB elimination goals.
    • Future strategies must integrate TB infection management, addressing priority populations and ethical considerations.
    • Emerging research in biomarkers, vaccines, and digital innovations holds promise for improved TB control.